COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Appraise ATP

Purpose of Study

The primary objective is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for ICD therapy. The incidence of all-cause shocks in subjects programmed with shocks only will be compared with subjects programmed to standard therapy (ATP and shock) to assess equivalency.

Trial Status


Eligibility Criteria

Boston Scientific transvenous ICD implanted because of 1) prior MI and left ventricular ejection fraction less than or equal to 30% OR 2) Ischemic or non-ischemic cardiomyopathy and LVEF 35%, and NYHA class II or III

Duration of Participation

Approximately 5 years

Contact Name: Lindsay Risk

Contact Phone: 515-633-3847

Contact Email: